(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

New chemical agents can detect Alzheimer's amyloid beta by MRI

What is it about?

A major barrier in the diagnosis and clinical monitoring of Alzheimer’s disease is the lack of safe and accessible diagnostic tools. This paper describes a novel class of compounds that address Such agents may enable the safe, noninvasive MRI detection of the amyloid-beta peptide, the primary causative agent of Alzheimer’s disease.

Why is it important?

A major barrier in the diagnosis and clinical monitoring of Alzheimer’s disease is the lack of safe and accessible diagnostic tools.

Read more on Kudos…
The following have contributed to this page:
John Voss
' ,"url"));